295 related articles for article (PubMed ID: 33939658)
1. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.
Fishbein L; Del Rivero J; Else T; Howe JR; Asa SL; Cohen DL; Dahia PLM; Fraker DL; Goodman KA; Hope TA; Kunz PL; Perez K; Perrier ND; Pryma DA; Ryder M; Sasson AR; Soulen MC; Jimenez C
Pancreas; 2021 Apr; 50(4):469-493. PubMed ID: 33939658
[TBL] [Abstract][Full Text] [Related]
2. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors.
Halfdanarson TR; Strosberg JR; Tang L; Bellizzi AM; Bergsland EK; O'Dorisio TM; Halperin DM; Fishbein L; Eads J; Hope TA; Singh S; Salem R; Metz DC; Naraev BG; Reidy-Lagunes DL; Howe JR; Pommier RF; Menda Y; Chan JA
Pancreas; 2020 Aug; 49(7):863-881. PubMed ID: 32675783
[TBL] [Abstract][Full Text] [Related]
3. Pheochromocytomas and Paragangliomas.
Tevosian SG; Ghayee HK
Endocrinol Metab Clin North Am; 2019 Dec; 48(4):727-750. PubMed ID: 31655773
[TBL] [Abstract][Full Text] [Related]
4. Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management.
Hamidi O
Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):146-154. PubMed ID: 30893083
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and management of metastatic pheochromocytoma and paraganglioma].
Jochmanová I; Lazúrová I
Vnitr Lek; 2017; 63(9):580-588. PubMed ID: 29120654
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
Lenders JW; Duh QY; Eisenhofer G; Gimenez-Roqueplo AP; Grebe SK; Murad MH; Naruse M; Pacak K; Young WF;
J Clin Endocrinol Metab; 2014 Jun; 99(6):1915-42. PubMed ID: 24893135
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma and paraganglioma.
Meyer-Rochow GY; Sidhu SB
Cancer Treat Res; 2010; 153():135-62. PubMed ID: 19957224
[No Abstract] [Full Text] [Related]
8. Clinical evaluation and treatment of phaeochromocytoma.
Davison AS; Jones DM; Ruthven S; Helliwell T; Shore SL
Ann Clin Biochem; 2018 Jan; 55(1):34-48. PubMed ID: 29027806
[TBL] [Abstract][Full Text] [Related]
9. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.
Chen H; Sippel RS; O'Dorisio MS; Vinik AI; Lloyd RV; Pacak K;
Pancreas; 2010 Aug; 39(6):775-83. PubMed ID: 20664475
[TBL] [Abstract][Full Text] [Related]
10. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
[TBL] [Abstract][Full Text] [Related]
11. Hereditary Neuroendocrine Tumors: Providing Comprehensive Care for Individuals Who Have a Germline Pathogenic Variant Associated With Paragangliomas and Pheochromocytomas.
Mahon SM
Clin J Oncol Nurs; 2021 Apr; 25(2):137-141. PubMed ID: 33739340
[TBL] [Abstract][Full Text] [Related]
12. [Phaeochromocytoma and paraganglioma].
Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L
Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938
[TBL] [Abstract][Full Text] [Related]
13. Emerging molecular markers of metastatic pheochromocytomas and paragangliomas.
Goncalves J; Lussey-Lepoutre C; Favier J; Gimenez-Roqueplo AP; Castro-Vega LJ
Ann Endocrinol (Paris); 2019 Jun; 80(3):159-162. PubMed ID: 31053249
[TBL] [Abstract][Full Text] [Related]
14. The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
Lima JV; Kater CE
Int Braz J Urol; 2023; 49(3):307-319. PubMed ID: 37115176
[TBL] [Abstract][Full Text] [Related]
15. Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies.
Schreiner F; Beuschlein F
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101347. PubMed ID: 31662271
[TBL] [Abstract][Full Text] [Related]
16. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.
Martucci VL; Pacak K
Curr Probl Cancer; 2014; 38(1):7-41. PubMed ID: 24636754
[No Abstract] [Full Text] [Related]
17. [Pheochromocytoma and paraganglioma: basics for the general practitioner].
Loosli N; Köhler BB; Pechère-Bertschi A; Karenovics W; Triponex F
Rev Med Suisse; 2014 Sep; 10(441):1650-2, 1654-5. PubMed ID: 25322623
[TBL] [Abstract][Full Text] [Related]
18. [Pheochromocytoma and paraganglioma in childhood: a report of 2 cases report].
Mosquera Gorostidi A; Justo Ranera A; Zakirian Denis SE; González Temprano N; Sagaseta de Ilúrdoz Uranga M; Molina Garicano J
An Pediatr (Barc); 2015 Jan; 82(1):e175-80. PubMed ID: 25082130
[TBL] [Abstract][Full Text] [Related]
19. Pheochromocytoma: a review.
Tsirlin A; Oo Y; Sharma R; Kansara A; Gliwa A; Banerji MA
Maturitas; 2014 Mar; 77(3):229-38. PubMed ID: 24472290
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas.
Al-Harthy M; Al-Harthy S; Al-Otieschan A; Velagapudi S; Alzahrani AS
Endocr Pract; 2009 Apr; 15(3):194-202. PubMed ID: 19364686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]